Publication | Open Access

Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period

Transplantation SurgeryOncologyIntestinal TransplantationTransplantationMultivisceral TransplantationImmunologyGastroenterologyEarly Post-operative PeriodGraft SurvivalTransplant SurgeryPharmacotherapyInduction AgentsImmunotherapyMedicineGraft Rejection